Close
Almac
Achema middle east

Inizio Engage launches new global powerhouse learning brand, Nazare

Note* - All images used are for editorial and illustrative purposes only and may not originate from the original news provider or associated company.

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Media Packs

Expand Your Reach With Our Customized Solutions Empowering Your Campaigns To Maximize Your Reach & Drive Real Results!

– Access the Media Pack Now

– Book a Conference Call

Leave Message for Us to Get Back

Related stories

Sanofi to Buy Vaccine Developer Dynavax in a $2.5b Deal

The French pharma giant, Sanofi, has started a $15.50...

AstraZeneca Commits $100mn for Pan-KRAS Inhibitor by Jacobio

AstraZeneca has gone ahead and committed $100 million to...

Laboratory Equipment Outsourcing Through CDMOs: Strategic and Cost Implications

Outsourcing laboratory infrastructure to CDMOs offers pharma companies critical agility, transforming fixed capital costs into flexible operational expenses while accessing cutting-edge technology like Cryo-EM.
- Advertisement -

Inizio Engage has announced the launch of Nazaré, a new learning and capability brand. Nazaré brings together 150+ experts in learning, life sciences, creativity, technology, and behavioral science. Nazaré is set to transform workplace learning in order to help companies maintain their leadership in evolving competitive landscapes by unlocking the potential of their people.

The new global learning and capability brand will be part of the Experience Design (XD) specialist area within Inizio Engage. This means Nazaré will draw on the rest of Inizio Engage XD’s in-house creative and executional capabilities in live events, environments, film, digital, and immersive technologies, as well as considering learning experience design more holistically alongside employee engagement.

Nazaré brings together Axiom, Cormis, Logicearth Learning Services and Ashfield Excellence Academy under one brand to support global organizations with a range of learning and capability programs, with an unparalleled level of expertise in end-to-end life sciences learning support for pharmaceutical and biotech companies across the product lifecycle. Nazaré will focus on designing and delivering world-class learning experiences that inspire an immediate and lasting change in performance.

Nazaré harnesses science, creativity, and technology to challenge how the Learning & Development industry creates impact for businesses. The brand name embodies a new wave in learning – emphasizing the power, agility, momentum, and impact that Nazaré will bring to its clients.

The launch sees the formation of a new global leadership team of Charlotte Morris, Managing Director, Global; Terri Harchar, Managing Director, North America; and Peter Carlin, Director Learning Technology & Platforms.

Commenting on the launch, Charlotte Morris, Global Managing Director, Nazaré said: “The launch of Nazaré is incredibly exciting because it means unlike other training providers, we go beyond simple knowledge transfer – we combine science, creativity, and technology to redefine the practice of instructional design. This enables us to transform the behavior of our clients’ people and the success of their businesses at the most pivotal moments.”

Russ Lidstone, President, Inizio Engage XD also comments: “Business leaders need evidence-based learning strategies and programs that inspire real behavior change. Nazaré provides a unique combination of learning, capability development, technology, creativity, and behavioral science to create learning that delivers real-world results.”

Latest stories

Related stories

Sanofi to Buy Vaccine Developer Dynavax in a $2.5b Deal

The French pharma giant, Sanofi, has started a $15.50...

AstraZeneca Commits $100mn for Pan-KRAS Inhibitor by Jacobio

AstraZeneca has gone ahead and committed $100 million to...

Laboratory Equipment Outsourcing Through CDMOs: Strategic and Cost Implications

Outsourcing laboratory infrastructure to CDMOs offers pharma companies critical agility, transforming fixed capital costs into flexible operational expenses while accessing cutting-edge technology like Cryo-EM.

Samsung Biologics to Buy US Drug Plant from GSK for $280M

On December 22, 2025, the news has been confirmed...

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Media Packs

Expand Your Reach With Our Customized Solutions Empowering Your Campaigns To Maximize Your Reach & Drive Real Results!

– Access theMedia Pack Now

– Book a Conference Call

Leave Message for Us to Get Back

Translate »